Association Between Potency Critical Quality Attributes and Clinical Efficacy Across Lentiviral Vector Cell and Gene Therapy Products

被引：0
|
作者：
Shestopalov, Ilya A. [1 ]
Jiang, Hancheng [1 ]
Gayron, Marisa [1 ]
d'Anjou, Marc [1 ]
Kral, Kelly [1 ]
Pierciey, Francis J. [1 ]
Colvin, Richard [1 ]
机构：
[1] Bluebird Bio, Somerville, MA USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
238
引用
收藏
页码：127 / 128
页数：2
相关论文
共 28 条
  • [1] ADVANCING LENTIVIRAL VECTOR MANUFACTURE FOR CLINICAL CELL AND GENE THERAPY
    Michelet, F.
    Szyniarowski, P.
    Radhakrishnan, S.
    Sin, W.
    Leo, V. Ivon
    Alagppan, D.
    Lam, P.
    Chan, L.
    CYTOTHERAPY, 2021, 23 (05) : S174 - S175
  • [2] Critical Quality Attributes for Supply of Clinical Plasmids for Cell and Gene Therapy Development
    Thiaville, Patrick
    MOLECULAR THERAPY, 2022, 30 (04) : 532 - 532
  • [3] Balancing efficacy and safety in lentiviral vector-mediated hematopoietic stem cell gene therapy
    Montini, Eugenio
    Naldini, Luigi
    Booth, Claire
    Kohn, Donald B.
    Aiuti, Alessandro
    MOLECULAR THERAPY, 2025, 33 (01) : 6 - 8
  • [4] Regulatory considerations for novel gene therapy products: A review of the process leading to the first clinical lentiviral vector
    Manilla, P
    Rebello, T
    Afable, C
    Lu, XB
    Slepushkin, V
    Humeau, LM
    Schonely, K
    Ni, YJ
    Binder, GK
    Levine, BL
    MacGregor, RR
    June, CH
    Dropulic, B
    HUMAN GENE THERAPY, 2005, 16 (01) : 17 - 25
  • [5] Pre-clinical safety and efficacy evaluation of GMP lentiviral vector in preparation for a clinical trial of hematopoietic stem cell gene therapy in MPS IIIA
    Ellison, Stuart M.
    Wood, Shaun
    Sergijenko, Ana
    Armant, Myriam
    Chan, Lucas
    Farzaneh, Farzin
    Jones, Simon
    Wynn, Rob
    Gaspar, Bobby
    Biffi, Alessandra
    Bigger, Brian
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S42 - S42
  • [6] Clinical outcomes of gene therapy with BB305 lentiviral vector for sickle cell disease and β-thalassaemia
    Ribeil, Jean-Antoine
    Cavazzana, Marina
    Touzot, Fabien
    Payen, Emmanuel
    Neven, Benedicte
    Lefrere, Francois
    Suarez, Felipe
    Magrin, Elisa
    Beuzard, Yves
    Cavallesco, Resy
    Chretien, Stany
    Bourget, Philippe
    Monpoux, Fabrice
    Pondarre, Corinne
    Bartolucci, Pablo
    Schmidt, Manfred
    von Kalle, Christof
    Kuypers, Frans A.
    Sandler, Laura
    Soni, Sandeep
    Semeraro, Michaela
    El Nemer, Wassim
    Hermine, Olivier
    De Montalembert, Mariane
    Blanche, Stephane
    Hacein-Bey-Abina, Salima
    Leboulch, Philippe
    HAEMATOLOGICA, 2017, 102 : 59 - 59
  • [7] Lentiviral Vector Use in Pre-Clinical Work for Gene and Cell Therapy Application - Method and Feasibility
    Genard, Romain
    Hung, Selly
    Padet, Lauriane
    Riffon, Renee
    Authier, Simon
    MOLECULAR THERAPY, 2021, 29 (04) : 136 - 136
  • [8] Clinical Outcomes of Gene Therapy with BB305 Lentiviral Vector for Sickle Cell Disease and β-Thalassemia
    Cavazzana, Marina
    Ribeil, Jean-Antoine
    Payen, Emmanuel
    Touzot, Fabien
    Neven, Benedicte
    Lefrere, Francois
    Suarez, Felipe
    Magrin, Elisa
    Beuzard, Yves
    Chretien, Stany
    Bourget, Philippe
    Monpoux, Fabrice
    Pondarre, Corinne
    Bartolucci, Pablo
    Schmidt, Manfred
    von Kalle, Christof
    Sandler, Laura
    Soni, Sandeep
    Semeraro, Michaela
    El Nemer, Wassim
    Hermine, Olivier
    de Montalembert, Mariane
    Blanche, Stephane
    Hacein-Bey-Abina, Salima
    Leboulch, Philippe
    MOLECULAR THERAPY, 2016, 24 : S111 - S112
  • [9] Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA
    Ellison, Stuart M.
    Liao, Aiyin
    Wood, Shaun
    Taylor, Jessica
    Youshani, Amir Saam
    Rowlston, Sam
    Parker, Helen
    Armant, Myriam
    Biffi, Alessandra
    Chang, Lucas
    Farzaneh, Farzin
    Wynn, Rob
    Jones, Simon A.
    Heal, Paul
    Gaspar, H. Bobby
    Bigger, Brian W.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 : 399 - 413
  • [10] Finding meaning: Potential relationship between critical quality attributes of MSC's and their Clinical efficacy in GvHD
    Torrents-Zapata, S.
    Codinach, M.
    Rodriguez, L.
    Fernandez-Sojo, J.
    Blanco, M.
    Alonso, L.
    Moron-Cazalilla, G.
    Elorza, I.
    Orti, G.
    Parody, R.
    Esquirol, A.
    Uria, M.
    Trabazo, M.
    Benitez, M.
    Badell, I.
    Diaz de Heredia, C.
    Querol, S.
    Vives, J.
    CYTOTHERAPY, 2020, 22 (05) : S108 - S109
123